New gene therapy trials aim to mend broken hearts
LONDON (Reuters) - British scientists are stepping up clinical tests of gene therapy in a bid to help people with advanced heart failure pump blood more efficiently. Researchers said on...
Home > Reviews
All Stories
UK watchdog accuses GSK over “pay-for-delay” drug deals
LONDON (Reuters) - Britain's competition body accused GlaxoSmithKline of market abuse for striking deals with three generic drugmakers that paid them to delay launching cheap copies of its antidepressant Seroxat....
UK watchdog accuses GSK over “pay-for-delay” drug deals
LONDON (Reuters) - Britain's competition body accused GlaxoSmithKline of market abuse for striking deals with three generic drugmakers that paid them to delay launching cheap copies of its antidepressant Seroxat....
Tamiflu and cancer drugs lift Roche above forecasts
LONDON (Reuters) - A spike in U.S. demand for flu drug Tamiflu and strong sales of mainstay cancer medicines lifted first-quarter sales at Roche Holding AG by a bigger-than-expected 5...
UK scientists develop safer foot-and-mouth vaccine
LONDON (Reuters) - British scientists have developed a new vaccine against foot-and-mouth disease that is safer and easier to manufacture, an advance they believe should greatly increase production capacity and...
UK scientists develop safer foot-and-mouth vaccine
LONDON (Reuters) - British scientists have developed a new vaccine against foot-and-mouth disease that is safer and easier to manufacture, an advance they believe should greatly increase production capacity and...
European Union in “denial” that sick economy costs lives, health experts say
LONDON (Reuters) - Europe's financial crisis is costing lives, with suicides and infectious diseases on the rise, yet politicians are not addressing the problem, health experts said on Wednesday. Deep...
European Union in “denial” that sick economy costs lives, health experts say
LONDON (Reuters) - Europe's financial crisis is costing lives, with suicides and infectious diseases on the rise, yet politicians are not addressing the problem, health experts said on Wednesday. Deep...
Biogen wins EU backing for big new MS drug hope
LONDON (Reuters) - European regulators have recommended approval of two new multiple sclerosis pills from Biogen Idec and Sanofi, both of which are expected to become major sellers. Friday's decision...
Biogen wins EU backing for big new MS drug hope
LONDON (Reuters) - European regulators have recommended approval of two new multiple sclerosis pills from Biogen Idec and Sanofi, both of which are expected to become major sellers. Friday's decision...